Efficacy of PARP Inhibitors, Bevacizumab and Platinum Based Chemotherapy in Treatment Regimen of Patients with BRCA1/2-mutated Ovarian Cancer
Vol. 28 No. 02 (2024), Review Article
Vol. 28 No. 02 (2024)

Efficacy of PARP Inhibitors, Bevacizumab and Platinum Based Chemotherapy in Treatment Regimen of Patients with BRCA1/2-mutated Ovarian Cancer

Review Article
Published 2025-06-13
  • Mahnoor Junaid Malik, Salman Jameel Malik
Mahnoor Junaid Malik, Salman Jameel Malik
PDF

How to Cite

1.
Mahnoor Junaid Malik, Salman Jameel Malik. Efficacy of PARP Inhibitors, Bevacizumab and Platinum Based Chemotherapy in Treatment Regimen of Patients with BRCA1/2-mutated Ovarian Cancer. sjrmu [Internet]. 2025 Jun. 13 [cited 2025 Jul. 12];28(02):129-32. Available from: https://supp.journalrmc.com/index.php/public/article/view/350
APA Chicago Harvard MLA Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

N/A

PDF